Prophylactic effect of rectal indomethacin plus nitroglycerin administration for preventing pancreatitis after endoscopic retrograde cholangiopancreatography in female patients | Zendy

Yunfeng Wang | Zendy; Bin Xu | Zendy; Wenzhong Zhang | Zendy; Jie Lin | Zendy; Gang Li | Zendy; Wei Qiu | Zendy; Yueming Wang | Zendy; Duo Sun | Zendy; Yongbing Wang | Zendy

Open Access

Prophylactic effect of rectal indomethacin plus nitroglycerin administration for preventing pancreatitis after endoscopic retrograde cholangiopancreatography in female patients

Author(s) -

Yunfeng Wang,

Bin Xu,

Wenzhong Zhang,

Jie Lin,

Gang Li,

Wei Qiu,

Yueming Wang,

Duo Sun,

Yongbing Wang

Publication year - 2020

Publication title -

annals of palliative medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.546

H-Index - 19

eISSN - 2224-5839

pISSN - 2224-5820

DOI - 10.21037/apm-20-1963

Subject(s) - medicine , pancreatitis , endoscopic retrograde cholangiopancreatography , placebo , anesthesia , clinical trial , suppository , randomized controlled trial , surgery , alternative medicine , pathology , pharmacology

Prophylactic pancreatic stent placement (PSP) and rectal indomethacin suppository are recommended to prevent post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP) in high-risk cases. Clinical trials on the use of nitroglycerin to reduce PEP have reached no definitive conclusion. Our study aimed to determine whether treatment with rectal indomethacin plus nitroglycerin could eliminate the need for PSP in patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research